Science Explorer Back to mapMap
Discussion
Researcher · Epic Sciences (United States) · United States

Rick Wenstrup

Rick Wenstrup publishes mostly in Oncology, Cancer Research and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, Prostate Cancer Treatment and Research and Cancer Cells and Metastasis.

OpenAlex
World rank
#2,390,666
of 7,710,434 ranked researchers
Rank in United States
#709,431
of 1,627,098
Works
44
Citations
183
Citations per work
4.2
h-index
6
i10-index 4Top 84% in Oncology
Rick Wenstrup

What does Rick Wenstrup research?

Rick Wenstrup's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (35%).

Health Sciences: 27 works · 61.6% of their workMedicine: 27 works · 61.6% of their workOncology: 13 works · 30.0% of their workPulmonary and Respiratory Medicine: 10 works · 23.3% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 8.3% of their workLife Sciences: 15 works · 35.0% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 35.0% of their workCancer Research: 12 works · 28.3% of their workMolecular Biology: 2 works · 5.0% of their workGenetics: 1 works · 1.7% of their workEverything else: 1 works · 3.4% of their workTHEIR WORKRick Wenstrup44works
Life Sciences35%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2761.6%
    1. Biochemistry, Genetics and Molecular Biology1535.0%
  3. Everything else13.4%
  1. 1Oncology30% of their works
  2. 2Cancer Research28% of their works
  3. 3Pulmonary and Respiratory Medicine23% of their works
  4. 4Radiology, Nuclear Medicine and Imaging8% of their works
  5. 5Molecular Biology5% of their works
  6. 6Genetics2% of their works

Research topics

Which keywords describe Rick Wenstrup's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, Biomarkers, Immunotherapy, Androgen Receptor, Prostate Cancer and Cancer Stem Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy373 topics
  2. Cancer Genomics271 topic
  3. Mutational Signatures271 topic
  4. Biomarkers262 topics
  5. Immunotherapy262 topics
  6. Androgen Receptor211 topic
  7. Prostate Cancer211 topic
  8. Cancer Stem Cells191 topic
  9. Tumor Metastasis191 topic
  10. Metastasis92 topics
  11. Genomic Profiles51 topic
  12. PET Imaging51 topic
  13. Radiopharmaceuticals51 topic
  14. Small-Cell Lung Cancer51 topic
  15. Breast Cancer41 topic
  16. CDK4/6 Inhibitors41 topic
  17. Cancer of Unknown Primary41 topic
  18. HIF-141 topic
  19. Tissue of Origin41 topic
  20. Warburg Effect41 topic

Where does Rick Wenstrup work?

Rick Wenstrup's main affiliation in the publication record is Epic Sciences (United States), United States.

How many publications and citations does Rick Wenstrup have?

OpenAlex counts 44 works and 183 citations for Rick Wenstrup, an h-index of 6, ranking #2,390,666 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Rick Wenstrup. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.